COVID-19 infections decrease total cholesterol, LDL-C, HDL-C, and apolipoprotein AI, A-II,
and B levels while triglyceride levels may be increased or inappropriately normal for the …

Numerous studies have observed a decrease in total cholesterol, LDL-C, HDL-C, and
apolipoprotein B and AI levels in patients with COVID-19 infections, similar to what is …

Metabolomics and lipidomics have been used in several studies to define the biochemical
alterations induced by COVID-19 in comparison with healthy controls. Those studies …

Plasma of COVID-19 patients contains a strong metabolomic/lipoproteomic signature,
revealed by the NMR analysis of a cohort of> 500 patients sampled during various waves of …

The complex manifestations of COVID-19 are still not fully decoded on the molecular level.
We combined quantitative the nuclear magnetic resonance (NMR) spectroscopy serum …

SARS-CoV-2 infection goes beyond acute pneumonia, as it also impacts lipid metabolism.
Decreased HDL-C and LDL-C levels have been reported in patients with COVID-19. The …

The global COVID-19 pandemic resulted in widespread harms but also rapid advances in
vaccine development, diagnostic testing, and treatment. As the disease moves to endemic …

Background. Metabolic alterations, particularly disorders of lipoprotein metabolism in COVID‐
19, may affect the course and outcome of the disease. This study aims at evaluating the …

High-density lipoproteins (HDLs) have multiple endothelioprotective properties. During
SARS-CoV-2 infection, HDL-cholesterol (HDL-C) concentration is markedly reduced, and …

Simple Summary Given the prevalence of COVID-19 infection, assessment of sequelae is
critical to public health. Recent studies revealed a higher incidence of resistant hypertension …